acetylcysteine has been researched along with Bone Marrow Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dokal, I; Hossain, U; Jackson, N; Kirwan, M; Plagnol, V; Pondarre, C; Tummala, H; Vulliamy, T; Walne, AJ | 1 |
Deloughery, TG; Hasler, BP; Muldoon, LL; Neuwelt, EA; Pagel, MA | 1 |
2 other study(ies) available for acetylcysteine and Bone Marrow Diseases
Article | Year |
---|---|
ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.
Topics: Acetylcysteine; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Damage; DNA Helicases; DNA Repair; Female; Gene Knockdown Techniques; HEK293 Cells; HeLa Cells; Hemoglobinuria, Paroxysmal; Histones; Humans; Male; Mitochondria; Mitomycin; Mutation; Pedigree; Phosphorylation; Reactive Oxygen Species; Sesquiterpenes | 2014 |
Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Topics: Acetylcysteine; Animals; Antimetabolites; Antineoplastic Agents, Alkylating; Aorta, Thoracic; Blood-Brain Barrier; Bone Marrow Diseases; Brain; Brain Neoplasms; Buthionine Sulfoximine; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Interactions; Female; Glutathione; Infusions, Intra-Arterial; Lung Neoplasms; Rats; Rats, Long-Evans; Tissue Distribution; Xenograft Model Antitumor Assays | 2001 |